U.S. Metals and Mining Stock News

In the second quarter of 2026, QCR Holdings, Inc. reported higher net interest income of US$67.92 million and net income of US$36.25 million, alongside net charge-offs of US$3.3 million, which were US$0.6 million lower than the prior quarter as the m2 portfolio winddown progressed. Over the same period, the company also completed a multi-quarter share repurchase program totaling 546,384 shares for US$43.29 million, underscoring an emphasis on capital return while earnings and credit metrics...

Sensient Technologies Corporation recently reported past second-quarter 2026 results showing higher sales of US$462.08 million and net income of US$51.36 million, alongside raised full-year 2026 diluted EPS guidance to a range of US$4.10–US$4.20. The company’s stronger earnings and increased guidance were accompanied by an affirmed quarterly dividend of US$0.41 per share, underscoring ongoing capital returns to shareholders. Next, we will examine how Sensient’s upgraded earnings guidance...

In July 2026, Kate Farms, Inc. reported that its High Protein Nutrition Shake would be available in more than 6,800 Walmart and CVS Health stores nationwide following continued retail expansion and a recent CVS launch. Earlier in July, CVS Health also opened new smaller, pharmacy-focused locations, underscoring a push to refine its retail footprint and emphasize in-person pharmacy care across diverse communities. Now, we’ll consider how CVS’s rollout of smaller, pharmacy-focused locations...

Vishay Precision Group stock has delivered a very strong 262.2% return over the past year, yet the valuation picture is mixed because the Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable discount while traditional market multiples suggest the shares are expensive. The 262.2% one year return sets high expectations for what Vishay Precision Group needs to deliver to justify the current share price. Future cash flow growth and margin durability can support the DCF view...

Why H.B. Fuller’s refinancing move matters for stock watchers H.B. Fuller (FUL) recently overhauled key debt facilities, refinancing $420 million in term loans, expanding its revolving credit capacity, extending maturities to 2031 and trimming interest margins, a balance sheet shift investors are now assessing. See our latest analysis for H.B. Fuller. Despite the refinancing and a recent dividend affirmation, H.B. Fuller’s share price has been under pressure, with a 30 day share price return...

DoorDash stock has delivered a strong 103.1% gain over the past three years, yet its valuation checks currently point to a company that screens as expensive rather than a clear bargain. DoorDash has returned 103.1% over three years, which sets a high bar for any further upside to be justified by fundamentals. Efforts to roll out autonomous delivery robots and expand AI driven customer support may support growth expectations, while heavy investment requirements and execution risks in these...

Analog Devices stock has delivered a strong 141.5% total return over the past 5 years, yet the latest valuation checks suggest the shares now lean expensive rather than clearly cheap. A 141.5% return over 5 years highlights how strongly Analog Devices has rewarded long term shareholders, which raises the bar for any new upside from here. Investor focus on cash generation across the sector, illustrated by Texas Instruments planning lower capital spending to support free cash flow, can support...

NiSource (NI) continues to attract attention from investors focusing on regulated utilities after a period of mixed share performance. The stock is down about 6.7% over the past month and roughly 5.5% over the past 3 months. See our latest analysis for NiSource. Over a longer horizon NiSource has delivered an 8.66% year to date share price return and a 13.97% total shareholder return over the past year. However, recent one month trading momentum has softened as the stock adjusts to shifting...

Nasdaq, Inc. recently reported second-quarter 2026 results showing revenue of US$1,500 million and net income of US$507 million, alongside confirming a quarterly dividend of US$0.3100 per share payable on September 25, 2026, and updating investors on the completion of a long-running share repurchase program initiated in 2014. At the same time, the dismissal with prejudice of a long-running patent dispute with Miami International Holdings removes a legal overhang and allows both sides to...

In the lead-up to its early August 2026 earnings release, Supernus Pharmaceuticals attracted attention after analysts highlighted its positive Earnings ESP and prior earnings outperformance. This heightened optimism around another potential earnings beat has sharpened focus on whether the company’s recent execution can support its longer-term CNS growth ambitions. With analysts pointing to a positive Earnings ESP as a key signal, we’ll now examine how this shapes Supernus Pharmaceuticals’...

What triggered the latest move in WEX stock WEX (WEX) drew fresh attention after reporting second quarter 2026 results, issuing new third quarter guidance and raising full year revenue expectations, alongside progress on share buybacks and a new Bluon partnership. See our latest analysis for WEX. The recent guidance upgrade and Bluon agreement appear to have shifted sentiment toward WEX, with a 30 day share price return of 28.96% and year to date share price return of 19.94%. However, the 5...

Jazz Pharmaceuticals recently reported that analysts had expected a very large year-over-year earnings increase to US$6.04 per share on revenues of about US$1.11 billion for the June 2026 quarter, alongside receiving a second consecutive Gold Stevie Award for Employer of the Year in the pharmaceutical industry. This combination of anticipated earnings strength and external recognition for workplace quality highlights both operational momentum and a culture that may support longer-term...

Dividend announcement puts Helmerich & Payne in focus Helmerich & Payne (HP) has come onto investor radars after announcing a cash dividend of $0.25 per share, alongside continued investment in digitalization and automation of its drilling operations. The dividend decision, combined with commentary that the stock may trade below some intrinsic value estimates, is prompting closer attention to how these technology initiatives could influence the company’s future revenue mix and margin...

Assurant (AIZ) drew fresh attention after appointing Kelli Ertel as Chief Communications Officer and Chief of Staff on July 23, 2026. This move adds communications and brand leadership to her existing responsibilities. See our latest analysis for Assurant. Set against this leadership change, Assurant’s share price has climbed 17.6% over the past 90 days and its 1 year total shareholder return stands at 52.1%, which indicates that positive momentum has been building. If this kind of move has...

Southside Bancshares, Inc. recently reported past second-quarter and first-half 2026 results showing higher net interest income and net income year-on-year, while also completing a US$35.36 million share repurchase program totaling 1,237,865 shares announced in July 2023. The combination of earnings growth and a fully executed buyback points to management’s focus on profitability and disciplined capital deployment, supported by lower net charge-offs of US$0.3 million in the quarter. With...

Why First Hawaiian stock is in focus after the latest earnings First Hawaiian (FHB) has come back into the spotlight after reporting second quarter 2026 earnings, confirming its quarterly cash dividend, and updating investors on loan charge offs and share repurchases. See our latest analysis for First Hawaiian. First Hawaiian shares trade at US$27.79 after a recent short term pullback, with the 30 day share price return down 5.96% and the 1 year total shareholder return at 15.25%. The 3 year...

Earlier in 2026, SELLAS Life Sciences Group’s CEO Angelos Stergiou underscored how AI and precision medicine could speed drug development and refine patient selection as the company nears a pivotal Phase 3 readout for its acute myeloid leukemia therapy. The remarks, combined with shifting institutional positioning and retail focus on potential partnerships or acquisitions following updated change-of-control terms, have sharpened attention on SELLAS’s future direction. We will now examine how...

In the last week, the United States market has been flat, but over the past 12 months, it has seen a 15% rise with earnings projected to grow by 17% annually. In this context of steady growth and positive forecasts, identifying stocks that are trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets.

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by 15%, with earnings forecasted to grow by 17% annually. In light of these conditions, investors might find value in stocks that combine financial strength with growth potential. Penny stocks, while often associated with smaller or newer companies, can offer unique opportunities for those looking to uncover hidden gems in the market.

In the last week, the United States market has been flat, though it is up 15% over the past year with earnings projected to grow by 17% annually in the coming years. In light of these conditions, identifying strong dividend stocks like First Financial Bancorp can be a strategic approach for investors seeking stable income and potential growth in their portfolios.

Investors in Ovintiv Inc. ( NYSE:OVV ) had a good week, as its shares rose 4.0% to close at US$60.08 following the...

Why Live Oak Bancshares Earnings Matter For Investors Live Oak Bancshares (LOB) just posted second quarter 2026 results, with higher net interest income, net income and earnings per share compared with a year earlier. Net charge offs also declined over the same period. See our latest analysis for Live Oak Bancshares. The latest earnings release and lower net charge offs appear to support renewed confidence in Live Oak Bancshares, with the share price at $42.18 and a year to date share price...

GSK has just announced a £1.9b cost cutting program alongside fresh investment in UK life sciences, and the market reaction has been quick, with the stock up 6% on the news. When a major pharmaceuticals and biotechnology group reshapes its R&D footprint and focuses on phase 3 trials, it can ripple across the sector. Some companies may see new competitive pressure, while others may benefit from partnership, supply chain or sentiment shifts. This article looks at 3 stocks from our...

Corsair Gaming (CRSR) moved further into the AI spotlight after presenting at AMD Advancing AI 2026 in San Francisco, highlighting its CORSAIR PRO workstations and on premises servers for business focused AI workloads. See our latest analysis for Corsair Gaming. The AI repositioning appears to be attracting fresh attention, with Corsair Gaming’s share price up 6.90% in the last day and delivering a 74.92% year to date share price return. However, the 3 year total shareholder return has...